论文部分内容阅读
该研究评估动脉高血压和行经皮冠状动脉介入(percutaneous coronary intervention,PCI)患者出血风险的相关性。动脉高血压对行PCI的冠状动脉疾病患者出血风险的影响尚不清楚。方法:该研究纳入14 180例行PCI的患者。应用出血学术研究联合会(Bleeding Academic Research Consortium,BARC)的标准定义出血。高血压定义为服用降压药治疗,或至少2次记录收缩压>140mm Hg(1mm Hg=0.133kPa)
The study assessed the association between arterial hypertension and bleeding risk in patients undergoing percutaneous coronary intervention (PCI). The impact of arterial hypertension on bleeding risk in patients with coronary artery disease undergoing PCI is unclear. METHODS: The study enrolled 14 180 patients undergoing PCI. Bleeding was defined by the criteria of the Bleeding Academic Research Consortium (BARC). Hypertension was defined as treatment with antihypertensive medication, or systolic blood pressure> 140 mm Hg (1 mm Hg = 0.133 kPa) was recorded at least twice